AMA Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, covers the latest on coronavirus spread and infection trends headed into the holidays. Also discussing RSV, the spike in flu cases and influenza antiviral treatments. American Medical Association CXO Todd Unger hosts.
Read More2022 Nobel Peace Prize nominee Peter Hotez, MD, PhD, discusses his coronavirus vaccine, CorbeVax, as well as his Paxlovid rebound infection experience, and growing concerns around monkeypox. American Medical Association CXO Todd Unger hosts.
Dr. Peter Hotez is dean of the National School of Tropical Medicine at Baylor College of Medicine, and co-director of the Texas Children’s Hospital Center for Vaccine Development in Houston.
Read MoreCOVID-19 boosters this September, CDC designates monkeypox as nationally notifiable condition as outbreak continues, and new CPT codes added, as covered by AMA Director of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. American Medical Association CXO Todd Unger hosts.
Read MoreNovavax vaccine dose, delivery, storage, side effects—and all the details doctors need to know with Sandra Fryhofer, MD, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup. American Medical Association CXO Todd Unger hosts.
AMA COVID-19 resource center for physicians: http://ama-assn.org/covid-19
Read MoreAMA CXO Todd Unger discusses the status of Covid vaccines for kids under 5 with Paul Offit, MD, director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children’s Hospital of Philadelphia. Dr. Offit is also a member of the FDA’s vaccine advisory committee.
Read MoreAMA CXO Todd Unger discusses the latest Johnson & Johnson COVID vaccine news with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering a newly released estimate for COVID-19 related deaths using excess mortality, as well as summer spikes of coronavirus cases, hospitalizations, and that masking up in airports or high-risk settings continues to reduce chances of COVID infection.
Read MoreAMA CXO Todd Unger reviews COVID-19 case numbers and the legal battle over mask mandates with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the CDC’s latest health alert for COVID therapies, as well as the FDA’s approval of Remdesivir to treat pediatric coronavirus patients (kids 12 and younger).
More information on the CDC’s health alert: https://emergency.cdc.gov/han/2022/han00463.asp
Read MoreAMA CXO Todd Unger reviews changes to the national mask mandate with AMA Director of Science, Medicine and Public Health Andrea Garcia, including which airlines no longer require masks and the cities still enforcing mask mandates on public transit. Also covering the emerging subvariants BA.2.12 and BA.2.12.1, a new COVID breath test, and why Americans over 60 should get a second booster shot.
Read MoreAMA CXO Todd Unger reviews COVID-19 trending topics and news related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering the FDA’s authorization of a second booster shot, as well as changes in COVID treatments and therapies. Additionally, uninsured patients may have to pay high prices out-of-pocket for COVID tests and vaccinations due to lack of federal funding and stalled budget approval.
Read MoreAMA CXO Todd Unger reviews COVID-19 news and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering what we know about the BA.2 Omicron subvariant, if a new surge is coming soon, the latest on booster shots and changing data collection on the pandemic.
Read More